Xtant Medical Holdings, Inc. (XTNT) Financial Ratios
17 years of historical data (2008–2024) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: 37.87
30Y Low37.9·High37.9
P/FCF
N/A
—
5yr avg: N/A
30Y Low32.4·High32.4
P/B Ratio
↓
1.80
-9% vs avg
5yr avg: 1.98
30Y Low1.4·High22.3
ROE
↑
-34.9%
↑-35% vs avg
5yr avg: -25.8%
30Y Low-395%·High2%
Debt/EBITDA
N/A
—
5yr avg: 13.96
30Y Low14.0·High14.0
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
XTNT Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Xtant Medical Holdings, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $81M | $59M | $143M | $62M | $48M | $34M | $21M | $19M | $10M | $7M | $28M |
| Enterprise Value | $110M | $88M | $161M | $59M | $46M | $50M | $94M | $91M | $147M | $135M | $134M |
| P/E Ratio → | -4.81 | — | 217.31 | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.69 | 0.50 | 1.57 | 1.07 | 0.87 | 0.64 | 0.33 | 0.26 | 0.13 | 0.08 | 0.47 |
| P/B Ratio | 1.80 | 1.38 | 2.79 | 1.82 | 1.55 | 2.35 | — | — | — | — | 3.14 |
| P/FCF | — | — | — | — | — | — | — | 32.38 | — | — | — |
| P/OCF | — | — | — | — | 109.01 | — | — | 15.71 | — | — | — |
P/E links to full P/E history page with 30-year chart
XTNT EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.75 | 1.76 | 1.02 | 0.84 | 0.94 | 1.46 | 1.26 | 1.77 | 1.50 | 2.26 |
| EV / EBITDA | — | — | — | — | — | 37.87 | 111.41 | — | — | — | — |
| EV / EBIT | — | — | 84.76 | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | 154.44 | — | — | — |
XTNT Profitability
Margins and return-on-capital ratios measuring operating efficiency
Xtant Medical Holdings, Inc. earns an operating margin of -10.3%. Operating margins have expanded from -11.7% to -10.3% over the past 3 years, signaling improving operational efficiency. A negative ROE of -34.9% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 58.2% | 58.2% | 60.8% | 55.4% | 58.8% | 64.5% | 65.7% | 60.2% | 60.6% | 69.2% | 65.9% |
| Operating Margin | -10.3% | -10.3% | -11.1% | -11.7% | -7.0% | -1.4% | -3.6% | -83.2% | -45.8% | -8.4% | -20.4% |
| Net Profit Margin | -14.0% | -14.0% | 0.7% | -14.6% | -8.8% | -13.2% | -12.7% | -97.1% | -63.4% | -21.7% | -3.7% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -34.9% | -34.9% | 1.5% | -26.1% | -21.4% | -48.4% | — | — | — | -2162.1% | -394.8% |
| ROA | -17.6% | -17.6% | 0.9% | -14.8% | -10.1% | -16.6% | -18.4% | -92.2% | -42.0% | -13.6% | -2.5% |
| ROIC | -12.8% | -12.8% | -15.2% | -16.8% | -9.6% | -1.9% | -6.2% | -85.5% | -28.6% | -4.8% | -14.6% |
| ROCE | -17.9% | -17.9% | -17.7% | -15.2% | -13.0% | -3.0% | -6.9% | -105.2% | -39.2% | -6.4% | -17.1% |
XTNT Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $29M ($35M total debt minus $6M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.82 | 0.82 | 0.46 | 0.50 | 0.55 | 1.28 | — | — | — | — | 12.70 |
| Debt / EBITDA | — | — | — | — | — | 13.96 | 92.73 | — | — | — | — |
| Net Debt / Equity | — | 0.67 | 0.35 | -0.09 | -0.05 | 1.12 | — | — | — | — | 11.98 |
| Net Debt / EBITDA | — | — | — | — | — | 12.20 | 86.54 | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | 122.06 | — | — | — |
| Interest Coverage | -2.90 | -2.90 | -3.46 | -3.99 | -3.87 | -0.13 | -0.41 | -5.92 | -2.57 | -0.62 | -1.56 |
XTNT Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Xtant Medical Holdings, Inc.'s current ratio of 2.35x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.00x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 3.24x to 2.35x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.35 | 2.35 | 2.82 | 3.24 | 4.00 | 1.22 | 3.43 | 2.88 | 1.53 | 1.57 | 2.10 |
| Quick Ratio | 1.00 | 1.00 | 1.22 | 2.10 | 2.38 | 0.39 | 1.72 | 1.44 | 0.67 | 0.73 | 1.04 |
| Cash Ratio | 0.22 | 0.22 | 0.25 | 1.33 | 1.65 | 0.09 | 0.56 | 0.56 | 0.11 | 0.08 | 0.30 |
| Asset Turnover | — | 1.25 | 0.99 | 0.96 | 1.01 | 1.29 | 1.50 | 1.56 | 0.78 | 0.62 | 0.41 |
| Inventory Turnover | 1.27 | 1.27 | 0.97 | 1.49 | 1.27 | 0.88 | 1.38 | 1.66 | 1.46 | 1.05 | 0.89 |
| Days Sales Outstanding | — | 64.31 | 82.88 | 68.34 | 47.25 | 47.08 | 57.13 | 50.50 | 56.18 | 77.02 | 94.63 |
XTNT Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Xtant Medical Holdings, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 0.5% | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | 3.1% | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $134M | $127M | $94M | $85M | $28M | $13M | $12M | $2M | $1M | $829709 |
Peer Comparison
Compare XTNT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 XTNTYou | $81M | -4.8 | — | — | 58.2% | -10.3% | -34.9% | -12.8% | — |
 ATEC | $1B | -7.3 | 3487.6 | 381.1 | 69.6% | -10.7% | -630.7% | -12.6% | 1425.2 |
 NVCR | $2B | -13.5 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 OSPN | $442M | 6.2 | 5.8 | 8.8 | 70.7% | 20.6% | 30.1% | 21.7% | 0.1 |
 GMED | $12B | 22.8 | 19.4 | 20.5 | 67.4% | 16.3% | 12.3% | 8.9% | 0.2 |
 OSIS | $4B | 27.6 | 17.4 | 70.6 | 34.3% | 12.7% | 16.5% | 11.5% | 2.6 |
 IART | $1B | -2.1 | 13.2 | — | 51.7% | 4.2% | -39.9% | 1.7% | 9.3 |
 AHCO | $2B | -21.9 | 5.6 | 7.1 | 17.5% | 5.7% | -4.6% | 4.0% | 3.2 |
 ZBH | $16B | 23.3 | 9.4 | 11.0 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 |
 SYK | $112B | 34.8 | 20.2 | 26.1 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 MDT | $99B | 21.5 | 14.3 | 19.2 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 17 years · Updated daily
See XTNT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XTNT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XTNT vs ATEC
Side-by-side business, growth, and profitability comparison vs Alphatec Holdings, Inc..
Start ComparisonXTNT — Frequently Asked Questions
Quick answers to the most common questions about buying XTNT stock.
What is Xtant Medical Holdings, Inc.'s P/E ratio?
Xtant Medical Holdings, Inc.'s current P/E ratio is -4.8x. This places it at the 50th percentile of its historical range.
What is Xtant Medical Holdings, Inc.'s ROE?
Xtant Medical Holdings, Inc.'s return on equity (ROE) is -34.9%. The historical average is -112.1%.
Is XTNT stock overvalued?
Based on historical data, Xtant Medical Holdings, Inc. is trading at a P/E of -4.8x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Xtant Medical Holdings, Inc.'s profit margins?
Xtant Medical Holdings, Inc. has 58.2% gross margin and -10.3% operating margin.